Treatment of chronic haemophilic synovitis in humans with D-penicillamine

Haemophilia

Volumn 9, Issue 1, 2003, Pages 64-68

  Corrigan Jr , James J ^a,b   Damiano, M L ^a   Leissinger, C ^b   Wulff, K ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

D penicillamine; Haemophilia; Synovitis

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CORTICOSTEROID; CYTOTOXIC AGENT; PENICILLAMINE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HEMARTHROSIS; HEMOPHILIA A; HUMAN; JOINT EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEINURIA; RASH; RHEUMATOID ARTHRITIS; SYNOVECTOMY; SYNOVIORTHESIS; SYNOVITIS; TREATMENT OUTCOME; VOMITING;

EID: 0037274105     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00676.x     Document Type: Article

References (26)

1. Hilgartner MW, Pochedly C. Hemophilia in the Child and Adult, 3rd edn. New York: Raven Press, 1989.
2. Arnold WD, Hilgartner MW. Hemophilic arthropathy. current concepts of pathogenesis and management. J Bone Joint Surg 1977; 59A: 287-305.
3. Eikhoff HH, Raderschadt G, Koch W, Brackmann HH. Control of synovium in haemophilia. Haemophilia 1998; 4: 511-3.
4. van Creveld S. Prophylaxis of joint hemorrhages in hemophilia. Acta Haemat 1964; 41: 206-14.
5. Miser AW, Miser JS, Newton WA. Intensive factor replacement for management of chronic synovitis in hemophilic children. Am J Pediatr Hemat/Onc 1986; 8: 66-9.
6. Stein H, Duthie BB. The pathogenesis of chronic haemophilic arthropathy. J Bone Joint Surg 1981; 63-B: 601-9.
7. Fernandez-Palazzi F. Treatment of acute and chronic synovitis by non-surgical means. Haemophilia 1998; 4: 58-23.
8. Nicol RD, Menelaus MB. Synovectomy of the knee in hemophilia. J Pediatr Orthoped 1986; 6: 33-3.
9. Luck JV, Kasper CK. Surgical management of advanced hemophilic arthropathy. Clin Orthoped 1989; 242: 60-82.
10. Thomas P, Hepburn B, Kim HC, Saidi P. Nonsteroidal anti-inflammatory drugs in the treatment of hemophilic arthropathy. Am J Hemat 1982; 12: 131-7.
11. Steven MM, Small M, Pinkerton L, Madhok R, Sturrock RD, Forbes CD. Non-steroidal anti-inflammatory drugs in haemophilic arthritis. Haemostasis 1985; 15: 204-9.
12. 32P chromic phosphate for treatment of hemophilic arthropathy. J Bone Joint Surg 1994; 76A: 482-8.
13. Mainardi CL, Levine PH, Werb Z, Harris ED Jr. Proliferative synovitis in hemophilia. Biochemical and morphologic observations. Arthritis Rheum 1978; 21: 137-44.
14. Roosendaal G, Mauser-Bunschoten EP, De Kleijn P et al. Synovium in haemophilic arthropathy. Haemophilia 1998; 4: 502-5.
15. Corrigan JJ Jr, Kolba KS, Gall EP et al. Treatment of hemophilic arthritis with D-penicillamine: a preliminary report. Am J Hemat 1985; 19: 255-64.
16. Inwood MJ, Killackey B, Startup SJ. The use and safety of ibuprofen in the hemophiliac. Blood 1983; 61: 709-11.
17. Hasiba U, Scanton PE, Lewis JH, Spero JA. Efficacy and safety of ibuprofen for hemophilic arthropathy. Arch Intern Med 1980; 140: 1583-5.
18. Hill HFH. Treatment of rheumatoid arthritis with penicillamine. Semin Arthritis Rheum 1977; 6: 361-88.
19. Jaffe IA. D-penicillamine. Bull Rheum Dis 1982; 32: 21-4.
20. Betts WH, Cleland LG, Gee DJ, Whitehouse MW. Effects of D-penicillamine on a model of oxygen-derived free radical mediated tissue damage. Agents Actions 1984; 14: 283-90.
21. Hottinger AF, Fine EG, Gurney ME, Zurn AD, Aebischer P. The copper chelator D-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 1997; 9: 1548-51.
22. Younes M, Weser U. Superoxide dismutase activity of copper-penicillamine: possible involvement of Cu (1) stabilized sulphur radical. Biochem Biophys Res Commun 1997; 78: 1247-53.
23. Lipsky PE. Immunosuppression by D-penicillamine in vitro: inhibition of the human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation by hydrogen peroxide and protection by monocytes. J Clin Invest 1984; 73: 53-65.
24. Nuss R, Kilcoyne RF, Geraghty S et al. MRI findings in hemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 2000; 6: 162-9.
25. Kean WF, Dwosh IL, Anastassiades TP, Ford PM, Kelly HG. The toxicity pattern Of D-penicillamine therapy. A guide to its use in rheumatoid arthritis. Arthritis Rheum 1980; 23: 158-64.
26. Halverson PB, Kozin F, Bernhard GC, Goldman AL. Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis. JAMA 1978; 240: 1870-1.